Magnus

Creating the next gen of neuromodulation technology to improve quality of life rapidly & effectively Our mission is to restore and sustain mental health.

Magnus Medical is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. Its first product is the SAINT™ Neuromodulation System, granted Breakthrough Device Designation and 510(k) clearance by the U.S. Food & Drug Administration (FDA) in September 2022 for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.

05/26/2026

Before Mental Health Awareness Month wraps up, we want to remind you of Sandy's journey to remission from depression that she suffered with for 60 years.

After trying everything and not getting lasting relief, she found SAINT® Depression Therapy.

You can listen to her testimony here: https://www.magnusmedical.com/patients/

05/05/2026

Mental Health Awareness Month is a reminder that awareness only goes so far. Patients also need access and people willing to fight for it.

This week, Magnus Chief Medical Officer and co-founder Brandon Bentzley, MD, PhD and Sr. Director of Market Access Tapusi Patel are in Washington, D.C., meeting with Congressional offices to advocate for sustainable reimbursement pathways for SAINT® Depression Therapy.

This is a necessary effort to make safe, accelerated, and rapid-remission treatments accessible to more patients with depression who've run out of options.

We're proud to be making that case on Capitol Hill this week.

hashtag hashtag hashtag hashtag hashtag

05/02/2026

Depression rates are on the rise, and too many suffer in silence. Breaking the silence on mental health and the stigma surrounding depression is necessary, but change can only happen when individuals speak up and systems step up to make an impact.

There are millions of Americans currently living with depression, and ~30% of them don't find relief through standard talk therapy or antidepressant medications.

That fact is at the center of what we stand for. No one should run out of options when it comes to their mental health.

03/25/2026

Big news for Texas. 🎉

UTHealth Houston is now the first SAINT® Depression Therapy provider in Texas, bringing this personalized treatment to patients in the Houston area and beyond.

SAINT is a non-invasive, FDA-cleared therapy completed in just 5 days. In clinical trials, 79% of patients with treatment-resistant depression achieved remission.

You deserve to feel like yourself again. And now, help is closer than ever.

03/24/2026

We are so proud of Sandy for sharing her remarkable story!

It takes incredible courage, not just to take that first step toward getting help, but to open up and share her experience so honestly and openly. Her story is a powerful reminder of what's possible.

A huge thank you to UAMS Psychiatric Research Institute for their dedication to bringing treatments like SAINT to those who need it most. Because of their work, more people like Sandy get the chance to reclaim their lives.

If you or someone you love is struggling, know that hope and help are out there.

03/17/2026

We are so proud to announce that SAINT® Depression Therapy is now available in Pennsylvania at UPMC's Center for Interventional Psychiatry!

For those in PA (and beyond) who have been seeking better depression treatment options, this is a moment of hope. We are confident that UPMC’s commitment to patient care, combined with the power of SAINT, will make a real difference.

03/05/2026

**Content Warning: Mentions of su***de**
Sandy lived in a dark hole for six decades. Today, she has her life back, thanks to SAINT®. Watch the full story of her depression journey, from a su***de attempt at age 12 to a long-awaited breakthrough just last year.

Watch her full story here: https://www.magnusmedical.com/patients/

03/03/2026

60 years of depression. 5 days of SAINT® Depression Therapy. A life reclaimed. Stay tuned for Sandy’s full story this week!

02/26/2026

Major depressive disorder (MDD) is a complex set of emotional, physical, and cognitive symptoms. If you've already tried medication and still don't feel better, it may be because you need a more precise, personalized treatment option.

02/20/2026

If you’ve tried medication or therapy without relief, it’s not a failure of willpower. Major Depressive Disorder (MDD) is a brain-based condition, often caused by circuits that have stopped communicating effectively. While many traditional treatments focus on managing symptoms over months, SAINT® Depression Therapy is designed to bring you to remission in just five days.

Unlike systemic medications that affect the entire body, SAINT uses personalized fMRI mapping to identify the unique target in your brain. This precision is part of how SAINT shows a 79% remission rate in an average of 2.6 days.

If previous treatments haven’t worked, you are not out of options. Discover a path to recovery that is mapped to you.

References:
79%: Cole et al. (2022)
2.6 days: Cole et al (2020)

Address

1350 Old Bayshore Highway, #600
Burlingame, CA
94010

Website

https://www.magnusmedical.com/

Alerts

Be the first to know and let us send you an email when Magnus posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Magnus:

Shortcuts

Want your business to be the top-listed Equipment Service in Burlingame?